Skip to main content
. 2015 Sep 15;7(9):141–147. doi: 10.4251/wjgo.v7.i9.141

Figure 4.

Figure 4

Overall survival and freedom from local progression at 2 years for 11 patients accrued to a phase II clinical trial for unresectable pancreatic cancer. Image borrowed from Ref. [19].